These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25098554)

  • 1. DNA markers in molecular diagnostics for hepatocellular carcinoma.
    Su YH; Lin SY; Song W; Jain S
    Expert Rev Mol Diagn; 2014 Sep; 14(7):803-17. PubMed ID: 25098554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCC and Tumor Biomarkers: Does One Size Fits All?
    Ozgor D; Otan E
    J Gastrointest Cancer; 2020 Dec; 51(4):1122-1126. PubMed ID: 32827068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
    Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
    Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomarkers in hepatocellular carcinoma.
    De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
    Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
    Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
    World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study.
    Pommergaard HC; Yde CW; Ahlborn LB; Andersen CL; Henriksen TV; Hasselby JP; Rostved AA; Sørensen CL; Rohrberg KS; Nielsen FC; Rasmussen A
    Mol Biol Rep; 2022 Feb; 49(2):1609-1616. PubMed ID: 34811635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
    Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
    Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation markers in the detection of hepatocellular carcinoma.
    Fu S; Debes JD; Boonstra A
    Eur J Cancer; 2023 Sep; 191():112960. PubMed ID: 37473464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring.
    Yang J; Lin N; Niu M; Yin B
    Aging (Albany NY); 2024 Jul; 16(14):11460-11474. PubMed ID: 39033781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma.
    Ziogas IA; Sioutas G; Mylonas KS; Tsoulfas G
    Microrna; 2020; 9(1):25-40. PubMed ID: 31218966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma.
    Tao K; Bian Z; Zhang Q; Guo X; Yin C; Wang Y; Zhou K; Wan S; Shi M; Bao D; Yang C; Xing J
    EBioMedicine; 2020 Jun; 56():102811. PubMed ID: 32512514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics.
    Yang N; Ekanem NR; Sakyi CA; Ray SD
    Adv Drug Deliv Rev; 2015 Jan; 81():62-74. PubMed ID: 25450260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.
    Howell J; Atkinson SR; Pinato DJ; Knapp S; Ward C; Minisini R; Burlone ME; Leutner M; Pirisi M; Büttner R; Khan SA; Thursz M; Odenthal M; Sharma R
    Eur J Cancer; 2019 Jul; 116():56-66. PubMed ID: 31173963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for the Early Detection of Hepatocellular Carcinoma.
    Parikh ND; Mehta AS; Singal AG; Block T; Marrero JA; Lok AS
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2495-2503. PubMed ID: 32238405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.
    Deng Z; Ji Y; Han B; Tan Z; Ren Y; Gao J; Chen N; Ma C; Zhang Y; Yao Y; Lu H; Huang H; Xu M; Chen L; Zheng L; Gu J; Xiong D; Zhao J; Gu J; Chen Z; Wang K
    Genome Med; 2023 Nov; 15(1):93. PubMed ID: 37936230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.